Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke (NCT07590076) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke
Canada840 participantsStarted 2026-06
Plain-language summary
The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:
1. After 3 months of being discharged from the hospital, does this additional volunteer support at home improve coping skills for stroke survivors?
2. Does the effects of the volunteer support last over 3 to 6 months after being discharged home?
Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.
Participants will:
* Either receive volunteer support over an 8-week time period OR receive no additional volunteer support
* Continue with their usual care plan and receive educational resources from the research team during the study
* Complete online surveys during study enrollment, at 3 months, and at 6 months after hospital discharge
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Confirmed diagnosis of stroke
* Either undergoing or recently completed in-patient rehabilitation within the last 3 weeks
* Lived at home pre-stroke
* Discharged directly home (to own residence or that of a family member)
* Live in one of the program implementation areas (i.e., Toronto, Ottawa)
Exclusion Criteria:
* Discharged to additional hospital inpatient care, nursing home, or other long-term care
* Inability to communicate in English
* Inability to provide informed consent due to cognitive deficits
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Coping at Time 1 as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Timeframe: Measured at 3 months post-hospital discharge